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Abstract Sacral neuromodulation (SNM) may be benefi-
cial in the treatment of patients with chronic pelvic pain,
although it is not an FDA-approved indication. We present
a case of a 51-year-old patient that presented with
symptoms of lower urinary tract dysfunction and clitoral
pain after an abdominal hysterectomy. Electrophysiological
evaluation suggested a pudendal nerve lesion. After failure
of conservative treatment, she was offered SNM as a
treatment for her voiding symptoms. During test stimula-
tion, she experienced only moderate improvement in
voiding symptoms, but a striking improvement in pain
symptoms. She underwent a two-stage implantation of a
neurostimulator with a successful outcome after 6 months’
follow-up. The results of this report suggest that SNM may
be effective in patients with neuropathic pelvic pain.
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Introduction
Sacral neuromodulation (SNM) is an accepted treatment for
lower urinary tract dysfunction refractory to conservative
treatment. It has also proven to be an effective treatment for
fecal incontinence and functional bowel disorders. Al-
though no FDA-approved indication exists, there are
several reports showing a beneficial effect of SNM
treatment in chronic pelvic pain conditions, such as
interstitial cystitis or vulvodynia [1, 2]. The results seem
promising, although the study populations are small and
long-term success has not been defined yet.
Clitoral pain is an uncommon pain condition, and very
little data exist about its prevalence. Gordon et al. reported
21 cases of clitoral pain syndromes, including one patient
with clitoral pain after a laparoscopic hysterectomy [3]. Their
study showed that a wide variety of conditions are associated
with clitoral pain syndromes (trauma, surgery, neurological
disease), although treatment was not discussed. We present a
case of a patient with clitoral pain following hysterectomy,
treated successfully with SNM therapy.
Case
A 51-year-old woman presented to our urological clinic with
persistent voiding symptoms, which developed shortly after
an abdominal hysterectomy done 6 months earlier. The
patient reported impaired bladder emptying requiring ab-
dominal straining, followed by a sensation of incomplete
emptying. She also complained of urinary incontinence
occurring during day and night, without perceiving urgency.
Coughing or sneezing did not elicit urinary incontinence.
Furthermore, the patient reported clitoral pain with
paresthesia and a bothersome orgasmic sensation. These
complaints also developed after the hysterectomy and were
continuously present. A hysterectomy with left ovariectomy
was performed for complex atypical endometrial hyperpla-
sia. Post-operatively, a hematoma of the vaginal apex
developed, which was treated conservatively. In the acute
stage, the patient complained of vaginal pain, with radiation
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more prominent in the clitoral area, and paresthesia also
developed. She reported that these symptoms increased
when having emotional stress. Due to her symptoms, she
was unable to have sexual intercourse and to participate in
social activities.
Further relevant medical history noted two vaginal
deliveries and a right-sided ovariectomy due to the presence
of a mature teratoma of the ovary. There was no history of
back injury or surgery, vaginal infections, sexually trans-
mitted diseases, genital trauma, or sexual abuse.
Physical examination showed normal external female
genitalia and pelvic examination was normal. Clinical
neurological examination was unremarkable, including
normal perineal sensation for touch and normal sacral
reflexes.
Urodynamic measurement revealed a bladder capacity of
340 ml. During voiding, detrusor hypocontractility and
inadequate sphincter relaxation was observed, with urethral
pressuresupto130cmH2O. Post-micturition residual volume
was 321 ml, with a voided volume of 65 ml. Incontinence
could not be demonstrated during the investigation.
Electrophysiological evaluation suggested the presence
of a peripheral motor neuron lesion of the pudendal nerve.
The bulbocavernosal reflex latency was increased to
54.8 ms (normal range 24–41 ms), and bladder–bulboca-
vernosus reflex latency was 83.6 ms (normal range 47–
79 ms). The latency of the pudendal somatosensory-evoked
potential was normal with a normal shape of the evoked
response.
Psychological evaluation showed signs of mild anxiety
and depression. The total score of the Hospital Anxiety and
Depression Scale was 16, with scores of 10 on the anxiety
subscale and 6 on the depression subscale.
The initial treatment consisted of pelvic floor physio-
therapy combined with clean intermittent self-catherization
(CIC). This treatment facilitated voiding, resulting in
reduced residual volumes below 100 ml, after which CIC
was discontinued. However, the complaints of urinary
incontinence persisted, and therefore anticholinergics were
added to the treatment. For the clitoral pain, amitriptylin
was started but was only temporarily effective. Additional
treatment with pregabalin, lamotrigin, and carbamazepin
gave partial relief of pain symptoms but was discontinued
because of side effects.
Due to failure of conservative treatment of voiding
symptoms, sacral neuromodulation was considered a
possible treatment option. The patient was screened for
SNM therapy with a tined-lead test stimulation. This
procedure involved placement of a quadripolar lead into
the third sacral foramen in order to stimulate the S3 nerve
root. During the screening period of 3 weeks, patient
symptoms were self-monitored using voiding diaries. The
test was considered successful if more than 50% was noted
in any of the studied parameters. Additionally, pain
symptoms were recorded before (baseline) and during test
stimulation using the visual analogue scale (VAS).
Evaluation of the voiding diaries showed less than 50%
improvement in any of the relevant voiding diary param-
eters (Table 1). The VAS scores however showed a
significant reduction in pain symptoms (Table 2). Although
the test stimulation was considered unsuccessful regarding
voiding symptoms, the marked decrease in pain as well as
the high patient satisfaction served as guidance to offer the
patient a permanent implantable neurostimulator. After
extensive counseling and informed consent that SNM is
an off-label treatment for clitoral pain, she received an
implant 3 weeks after the tined-lead test stimulation.
After 6 months, VAS scores still showed a significant
improvement (Table 2) in pain symptoms. The patient
reported to be very satisfied with the treatment and had
resumed her daily activities. No improvement in bladder
function was noted: bladder emptying was still difficult and
incontinence persisted.
Discussion
The cause of the clitoral pain in this patient is unknown and
probably multifactorial. Repeated minor trauma of the
pelvic floor and pudendal nerve may have accumulated
due to the vaginal deliveries and pelvic surgery, leading to
the measurable pudendal nerve lesion. SNM shows to be
beneficial in improving clitoral pain and the effect persists
Table 1 Voiding diary parameters at baseline and during test
stimulation. In the last column, the amount of improvement is shown
as a percentage of the baseline data
Parameter Baseline Test
stimulation
Improvement
(%)
Voided volume/void (ml) 217 263 +36
Number of voids/day 12.3 8.9 −28
Number of leakages/day 5.4 3.4 −37
Number of pads/day 1.2 1.0 −11
Table 2 Overview of the VAS pain scores filled out by the patient
before and during SNM treatment
VAS score (0–100) Baseline Test
Stimulation
6months
follow-up
Pain at the moment 75 15 0
Pain during last week 70 10 5
Pain in best period 40 0 0
Pain in worst period 85 35 10
1306 Int Urogynecol J (2010) 21:1305–1307already for up to 6 months post-implantation. Previous
studies that evaluated the effect of SNM on chronic
idiopathic pelvic pain have shown positive results. Siegel
et al. reported a significant improvement in pain symptoms
in six out of ten patients with pelvic pain, which persisted
after a median follow-up of 19 months [4]. Yet, no previous
studies evaluated the effect of SNM treatment in clitoral
pain. Although SNM was used as an off-label treatment for
clitoral pain in our case, the results of this report suggest
that the application of SNM in patients with clitoral pain
might be effective.
Acknowledgement Randall Leong assisted with the discussion of
this paper.
Conflicts of interest T. Marcelissen: none; Ph. Van Kerrebroeck is
consultant and speaker for Medtronic; S. De Wachter is speaker for
Medtronic.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Everaert K et al (2001) The pain cycle: implications for the
diagnosis and treatment of pelvic pain syndromes. Int Urogynecol J
Pelvic Floor Dysfunct 12(1):9–14
2. Zabihi N et al (2008) Short-term results of bilateral S2–S4 sacral
neuromodulation for the treatment of refractory interstitial cystitis,
painful bladder syndrome, and chronic pelvic pain. Int Urogynecol
J Pelvic Floor Dysfunct 19(4):553–557
3. Gordon AS (2002) Clitoral pain: the great unexplored pain in
women. J Sex Marital Ther 28(Suppl 1):123–128
4. Siegel S et al (2001) Sacral nerve stimulation in patients with
chronic intractable pelvic pain. J Urol 166(5):1742–1745
Int Urogynecol J (2010) 21:1305–1307 1307